tiprankstipranks
Trending News
More News >
Gyre Therapeutics (GYRE)
NASDAQ:GYRE

Gyre Therapeutics (GYRE) Revenue

Compare
810 Followers

Gyre Therapeutics Revenue

Gyre Therapeutics had a revenue of 27.87M in the quarter ending Dec 31, 2024, with 9.35%. This bring the company's revenue in the last twelve months to 105.76M, Increased -1.96%. In the fiscal year ending Dec 31, 2024, Gyre Therapeutics had annual revenue of 105.76M with -6.78% growth.
Revenue (ttm)
105.76M
Revenue Growth
P/S Ratio
6.56
Revenue/Employee
$182,655
Employees
579
Market Cap
$693.68M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
105.76M-7.69M-6.78%
Dec 31, 2023
113.45M112.66M+14,188.41%
Dec 31, 2022
794.00K-6.54M-89.18%
Dec 31, 2021
7.34M-13.61M-64.97%
Dec 31, 2020
20.95M+∞%
Dec 31, 2019
0.00-6.00K-100.00%
Dec 31, 2018
6.00K-1.01M-99.41%
Dec 31, 2017
1.02M619.00K+155.14%
Dec 31, 2016
399.00K
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis